Abstract: Systems and methods for automated laser microdissection are disclosed including automatic slide detection, position detection of cutting and capture lasers, focus optimization for cutting and capture lasers, energy and duration optimization for cutting and capture lasers, inspection and second phase capture and/or ablation in a quality control station and tracking information for linking substrate carrier or output microdissected regions with input sample or slide.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Methods and systems for a transportation vehicle are provided. One exemplary method includes generating by a processor a master instruction set with a routing plan for loading data to and from a transportation vehicle using one or more networking links; creating by the processor a transportation side instruction set for loading and offloading data from the transportation vehicle, the transportation side instruction set being based on the master instruction set; using the master instruction set, the local instruction set and the transportation side instruction set to automatically load data to and from the transportation vehicle using the one or more network links to meet an objective of the master instruction set; and monitoring data loading to and from the transportation vehicle for making any changes to meet an objective of the master instruction set based on delivery time, cost or both delivery time and cost.

Abstract: Methods and systems for a transportation vehicle are provided. One exemplary method includes generating by a processor a master instruction set with a routing plan for loading data to and from a transportation vehicle using one or more networking links; creating by the processor a transportation side instruction set for loading and offloading data from the transportation vehicle, the transportation side instruction set being based on the master instruction set; using the master instruction set, the local instruction set and the transportation side instruction set to automatically load data to and from the transportation vehicle using the one or more network links to meet an objective of the master instruction set; and monitoring data loading to and from the transportation vehicle for making any changes to meet an objective of the master instruction set based on delivery time, cost or both delivery time and cost.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.

Abstract: Systems and methods for automated laser microdissection are disclosed including automatic slide detection, position detection of cutting and capture lasers, focus optimization for cutting and capture lasers, energy and duration optimization for cutting and capture lasers, inspection and second phase capture and/or ablation in a quality control station and tracking information for linking substrate carrier or output microdissected regions with input sample or slide.

Abstract: The present invention relates to polyclonal antibodies directed to mammalian FAA and methods of detecting the presence of FAA in semen by polyclonal antibody assay. This invention pertains to methods of predicting which candidates within a male mammalian population are likely to be the most fertile, by assaying for the presence and/or localization of FAA by utilizing polyclonal antibodies generated against recombinant FAA.

Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.

Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.

Abstract: A connector for coupling pipe sections which may be either aligned or misaligned axially, the connector having a male fitting, a female fitting which mates with the male fitting and a retaining means which can be connected to the female fitting to hold the male fitting in place against the female fitting. In one embodiment, the retaining means comprises a hammer nut which has a retaining surface. The retaining surface of the hammer nut contacts a rear surface of a first one of the flanges for urging this flange forward. The hammer nut has threads which are complementary to a set of threads on the second flange. When the hammer nut is threaded onto the second flange, the first and second flanges are pulled together. The retaining surface of the hammer nut and the rear surface of the first flange have complementary spherical shapes so that the hammer nut can rotate and swivel with respect to the flange.

Abstract: A packaged personal cleansing product comprising: (i) a foaming composition, wherein the foaming composition comprises less than 25% by weight, preferably less than 15% by weight, of water, at least 18% by weight of surfactant, wherein the surfactant comprises an anionic surfactant selected from alkyl glyceryl ether sulfonates, methyl acyl taurates, fatty acyl glycinates, N-acyl glutamates, acyl isethionates, acyl ethoxylated isethionates, acyl short chain branched isethionates, paraffin sulphonates, alpha-olefin sulphonates, fatty amide ethoxylated carboxylates, alkyl sulfosuccinates, alkyl ethoxysulphosuccinates, alpha-sulfonated fatty acids, their salts and/or their esters, alkyl phosphate esters, ethoxylated alkyl phosphate esters, acyl sarcosinates, and mixtures thereof, (ii) propellant gas; and (iii) a container for (i) and (ii); characterised in that the propellant gas comprises carbon dioxide, nitrous oxides, or mixtures thereof and that the viscosity of the foaming composition, measured at 20° C.

Abstract: Cured cementitious compositions having a modulus of rupture of greater than 15 MN/m.sup.2 are prepared by curing and drying a homogeneous uncured cementitious composition which comprises in defined proportions hydraulic cement, water and a selected water-dispersible polymer.